These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1676546)

  • 1. Effects of N-terminal peptide of Glu-plasminogen on the activation of Glu-plasminogen and its conversion to Lys-plasminogen.
    Urano T; Takada Y; Takada A
    Thromb Res; 1991 Feb; 61(4):349-59. PubMed ID: 1676546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational change of plasminogen: effects of N-terminal peptides of Glu-plasminogen.
    Takada Y; Urano T; Takada A
    Thromb Res; 1993 Apr; 70(2):151-9. PubMed ID: 8391730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
    Takada A; Takada Y
    Thromb Res; 1982 Sep; 27(6):671-7. PubMed ID: 6129717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface.
    Hajjar KA; Nachman RL
    J Clin Invest; 1988 Nov; 82(5):1769-78. PubMed ID: 3141482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of the synergistic effect between oversulfated chondroitin-6-sulfate and lysine or 6-aminohexanoic acid in enhancing the in-vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinase.
    Kouemo S; McMillan E; Doctor V
    Blood Coagul Fibrinolysis; 2010 Jul; 21(5):425-30. PubMed ID: 20445443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activation of two isozymes of glu-plasminogen (I and II) by urokinase and streptokinase.
    Takada A; Takada Y
    Thromb Res; 1983 Jun; 30(6):633-42. PubMed ID: 6351345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tranexamic acid on the conversion of Glu-plasminogen I and II to its Lys-forms.
    Takada A; Takada Y
    Thromb Res; 1985 Oct; 40(2):171-9. PubMed ID: 2933845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fucoidan during activation of human plasminogen.
    Doctor VM; Hill C; Jackson GJ
    Thromb Res; 1995 Aug; 79(3):237-47. PubMed ID: 8533120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of Glu- and Lys-plasminogen by elastase in the presence or absence of tranexamic acid.
    Takada A; Sugawara Y; Takada Y
    Thromb Res; 1988 Apr; 50(2):285-94. PubMed ID: 3394116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of heparan sulfate analogue or other sulfated polysaccharides on the activation of plasminogen by t-PA or u-PA.
    Takada Y; Urano T; Takada A
    Thromb Res; 1994 Mar; 73(5):301-11. PubMed ID: 8016815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fibrinogen and fibrin on the activation of Glu- and Lys-plasminogen by urokinase.
    Takada A; Takada Y; Sugawara Y
    Thromb Res; 1984 Mar; 33(6):561-9. PubMed ID: 6539003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino-terminal fragment of urokinase-type plasminogen activator inhibits its plasminogen activation.
    Sun Z; Zhang PX; Wang P; Gurewich V; Shen HY; Liu JN
    Thromb Res; 2002 Apr; 106(2):105-11. PubMed ID: 12182908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of Glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface.
    Gong Y; Kim SO; Felez J; Grella DK; Castellino FJ; Miles LA
    J Biol Chem; 2001 Jun; 276(22):19078-83. PubMed ID: 11264290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analyses of the activation of Glu-plasminogen by urokinase in the presence of fibrin, fibrinogen or its degradation products.
    Watahiki Y; Takada Y; Takada A
    Thromb Res; 1987 Apr; 46(1):9-18. PubMed ID: 3590117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the activation rates of plasminogen by tissue plasminogen activator and urokinase.
    Takada A; Shizume K; Cho M; Takada Y
    Thromb Res; 1987 Feb; 45(4):371-81. PubMed ID: 2437668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide.
    Cockell CS; Marshall JM; Dawson KM; Cederholm-Williams SA; Ponting CP
    Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):99-105. PubMed ID: 9639568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies detect receptor-induced binding sites in Glu-plasminogen.
    Han J; Baik N; Kim KH; Yang JM; Han GW; Gong Y; Jardí M; Castellino FJ; Felez J; Parmer RJ; Miles LA
    Blood; 2011 Aug; 118(6):1653-62. PubMed ID: 21680799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
    FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A battery of monoclonal antibodies that induce unique conformations to evolve cryptic but constitutive functions of plasminogen.
    Madoiwa S; Arai K; Ueda Y; Ishizuka M; Mimuro J; Asakura S; Matsuda M; Sakata Y
    J Biochem; 1997 Feb; 121(2):278-87. PubMed ID: 9089401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.